logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
Expert Opinion on Therapeutic Patents cover

Expert Opinion on Therapeutic Patents

IF4.6
Papers2600
Citations4317
Journal Papers 3029
Publication Date
delete
A patenting perspective of IKZF2 molecular glue degraders (2020-present)
deleteExpert Opinion on Therapeutic Patents
IF4.6
delete2026-10-13
delete0
PREAI
deleteXuqing Zhang
deleteShare
deleteSave
Progress with FAK inhibitors in the patent literature (2020-present)
deleteExpert Opinion on Therapeutic Patents
IF4.6
delete2026-09-20
delete0
PREAI
deleteBing-Bing Chen; Rui-Peng Feng; Jin-Bo Niu; Jian Song; Yuan-Bo Cui; Sai-Yang Zhang
deleteShare
deleteSave
Aurora kinase inhibitors: an updated patent review (2021–present)
deleteExpert Opinion on Therapeutic Patents
IF4.6
delete2026-09-15
delete0
PREAI
deleteYao-Sheng Zhang; Hong-Yu Zhang; Junmin Zhang; Shi-Wu Chen
deleteShare
deleteSave
Overcoming the blood–brain barrier for therapeutics targeting neurodegenerative diseases: a patent review (2020–present)
deleteExpert Opinion on Therapeutic Patents
IF4.6
delete2026-08-31
delete0
PREAI
deleteDaowei Huang; Roujun Lu; Ruijing Tang; Jiarui Sun; Zhipei Sang
deleteShare
deleteSave
Selective PARP1 inhibitors (2021–2025): patent landscape, structural evolution, and future therapeutic opportunities
deleteExpert Opinion on Therapeutic Patents
IF4.6
delete2026-08-24
delete0
PREAI
deleteJilong Duan; Yanjing Duan; Dongling Gu; Jia Yang; Fenghua Kang; Youchao Deng; Dongsheng Cao
deleteShare
deleteSave
Helicase-primase inhibitors as next-generation anti-HSV agents: from current clinical status to structure–activity relationships and patent coverage
deleteExpert Opinion on Therapeutic Patents
IF4.6
delete2026-08-05
delete0
PREAI
deleteChristian Gege; Gerald Kleymann
deleteShare
deleteSave
T-type calcium channel blockers: a review of recent advances (2018–2025)
deleteExpert Opinion on Therapeutic Patents
IF4.6
delete2026-08-04
delete0
PREAI
deleteYasinalli Tamboli; Laurent Ferron; Gerald W. Zamponi
deleteShare
deleteSave
Myeloperoxidase (MPO) inhibitors: an updated patent review (2020 - present)
deleteExpert Opinion on Therapeutic Patents
IF4.6
delete2026-07-30
delete0
PREAI
deleteZhiwei Meng; Dan Chen; Xingyu Yao; Feng Wang; Zhouling Xie
deleteShare
deleteSave
A patent review of mutant-selective PI3Kα inhibitors for the treatment of different cancers (2021–2025)
deleteExpert Opinion on Therapeutic Patents
IF4.6
delete2026-07-30
delete0
PREAI
deleteHaixiang Qi; Jiayang Wen; Heng Xu
deleteShare
deleteSave
New insights on anticancer glucocorticoid receptor modulators: a patent review (2020-present)
deleteExpert Opinion on Therapeutic Patents
IF4.6
delete2026-06-19
delete0
PREAI
deleteMartina Franzin; Marianna Lucafò; Debora Curci; Giuliana Decorti; Gabriele Stocco
deleteShare
deleteSave
An updated review of discoidin domain receptor 1 (DDR1) modulators (2020-present)
deleteExpert Opinion on Therapeutic Patents
IF4.6
delete2026-06-10
delete0
PREAI
deleteYunliang Zhang; Zhen Wang; Ke Ding
deleteShare
deleteSave
An update on PDGFR inhibitors: a patent review (2020 - present)
deleteExpert Opinion on Therapeutic Patents
IF4.6
delete2026-05-27
delete0
PREAI
deleteSisir Nandi; Sarfaraz Ahmed; Soubhik Barma; Rishita Dey; Asmita Samadder
deleteShare
deleteSave
Recent advances in the discovery of PKMYT1-targeting drugs: a patent review (2021–2025)
deleteExpert Opinion on Therapeutic Patents
IF4.6
delete2026-05-21
delete0
PREAI
deleteYazhou Wang; Chao Wang; Feng Ren; Alex Zhavoronkov; Xiao Ding
deleteShare
deleteSave
PCSK9 inhibitors: an updated patent review 2024–2025
deleteExpert Opinion on Therapeutic Patents
IF4.6
delete2026-05-21
delete0
PREAI
deleteEnrico Mario Alessandro Fassi; Marco Albani; Lorenza D’Adduzio; Erica Ginevra Milano; Carmen Lammi; Giovanni Grazioso
deleteShare
deleteSave
An updated patent review of histone deacetylase 6 inhibitors in neurodegenerative diseases (2020–2025)
deleteExpert Opinion on Therapeutic Patents
IF4.6
delete2026-05-20
delete0
PREAI
deleteSida Shen
deleteShare
deleteSave
A patent review of LPAR1 antagonists (2010 – present)
deleteExpert Opinion on Therapeutic Patents
IF4.6
delete2026-05-17
delete0
PREAI
deleteJiaxing Zhao; Yuxing Li; Wangshan Zheng; Yang Liu; Yan Yang; Yan Leng; Shiyu Wei; Jun Lou; Xiaofei Shang; Deping Tang
deleteShare
deleteSave
Small molecule agonists of Toll-like receptors 7 and 8: an updated patent review 2021 – 2025
deleteExpert Opinion on Therapeutic Patents
IF4.6
delete2026-05-15
delete0
PREAI
deleteAkash M. Patel; Natalia Chernyak; W. Michael Seganish
deleteShare
deleteSave
A patent review of VEGFR-2 inhibitors: an update (2022 – present)
deleteExpert Opinion on Therapeutic Patents
IF4.6
delete2026-04-26
delete0
PREAI
deleteThoraya A. Farghaly; Marwa F. Harras; Amani M. R. Alsaedi; Sami A. Al-Hussain; Nadia T. Al-Qurashi; Sayed M. Riyadh; Magdi E. A. Zaki; Shadia M. Hussein
deleteShare
deleteSave
Activin receptor-like kinase 5 (ALK5) inhibitors: a patent review (2013-present)
deleteExpert Opinion on Therapeutic Patents
IF4.6
delete2026-04-19
delete0
PREAI
deleteXin-Yi Huang; Chao-Qun Yu; Xin Wang; Zhen Guo; Cheng-Hua Jin
deleteShare
deleteSave
A patent review of NLRP3 inhibitors for inflammatory diseases (2023-present)
deleteExpert Opinion on Therapeutic Patents
IF4.6
delete2026-04-10
delete0
PREAI
deleteJannatun N. Namme; Yiming Xu; Elijah McClendon; Can Zhang; Shijun Zhang
deleteShare
deleteSave